Literature DB >> 22870128

IgM multiple myeloma presenting with bleeding tendency: a case report with immunophenotype analysis.

Ling Zheng1, Zhiyong Zeng, Junfang Lin, Junmin Chen.   

Abstract

IgM multiple myeloma (MM) is an extremely rare lymphoproliferative disease associated with an aggressive clinical course. However, the diagnosis of IgM MM may be complicated by Waldenstrom's macroglobulinemia (WM), particularly when clinical manifestations and morphological features are not typical. It is crucial to distinguish between IgM MM and WM as their prognoses and treatment strategies are different. We report a case of IgM MM presenting with bleeding tendency and an immunophenotype analysis using flow cytometry and immunohistochemistry. Bone marrow cells exhibited a typical phenotype for plasma cells, expressing monoclonal cytoplasmatic IgL-λ, CD38 and CD138 instead of pan-B cell antigens CD19, CD20 and CD22, which are characteristic of the typical immunophenotype of WM. Therefore, the diagnosis of IgM MM was confirmed in this case, highlighting the significance of detailed immuno-phenotypic evaluation when clinical and morphological features are atypical.

Entities:  

Year:  2010        PMID: 22870128      PMCID: PMC3412457          DOI: 10.3892/ol.2010.216

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  11 in total

1.  IgM multiple myeloma: report of four cases and review of the literature.

Authors:  Ombretta Annibali; Maria Teresa Petrucci; Patrizia Del Bianco; Cristiano Gallucci; Anna Levi; Robin Foà; Giuseppe Avvisati
Journal:  Leuk Lymphoma       Date:  2006-08

2.  IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14).

Authors:  Sylvia Feyler; Sheila J M O'Connor; Andy C Rawstron; Chezhian Subash; Fiona M Ross; Guy Pratt; Mark T Drayson; John Ashcroft; Gordon Cook; Roger G Owen
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998

Review 3.  [IgM myeloma: 6 cases and a review of the literature].

Authors:  A De Gramont; B Grosbois; J L Michaux; A M Peny; J P Pollet; N Smadja; M Krulik; J Debray; J F Bernard; M Monconduit
Journal:  Rev Med Interne       Date:  1990 Jan-Feb       Impact factor: 0.728

4.  IgM myeloma: a report of four cases.

Authors:  T Dierlamm; E Laack; J Dierlamm; W Fiedler; D-K Hossfeld
Journal:  Ann Hematol       Date:  2002-02-16       Impact factor: 3.673

Review 5.  Waldenström macroglobulinemia.

Authors:  Arun Vijay; Morie A Gertz
Journal:  Blood       Date:  2007-02-15       Impact factor: 22.113

6.  Waldenstroöm's macroglobulinemia with lytic osseous lesions and plasma-cell morphology. Report of a case.

Authors:  H H Berman
Journal:  Am J Clin Pathol       Date:  1975-03       Impact factor: 2.493

7.  IgM myeloma: case report with immunophenotypic profile.

Authors:  B Haghighi; R Yanagihara; P J Cornbleet
Journal:  Am J Hematol       Date:  1998-12       Impact factor: 10.047

Review 8.  Multiple myeloma.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Blood       Date:  2008-03-15       Impact factor: 22.113

9.  IgM multiple myeloma: a diagnostic challenge in a patient with coexisting chronic lymphocytic leukaemia.

Authors:  Saman Hewamana; Chris Pepper; Steve Couzens; Alun Thomas; Steven Knapper
Journal:  Int J Hematol       Date:  2008-10-11       Impact factor: 2.490

10.  IgM multiple myeloma presenting with spinal cord compression caused by a plasmacytoma: A case report.

Authors:  Ihssan Tahan; Jim Seale; David Edwards
Journal:  Cases J       Date:  2008-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.